Fundraising FoxOMX Ventures — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers.
BiotechDeep TechHardwareHealthtechPleasanton, US
Serge Saxonov(Founder)inBen Hindson(Founder)inBrad Crutchfield(Chief Commercial Officer)Jean Philibert(Chief People Officer)Eric S Whitaker(General Counsel)inJustin McAnear(Chief Financial Officer)
Co-investorsFoothill VenturesForesite CapitalKhosla VenturesPaladin Capital GroupSoftBank Vision FundVenrock+4 more
Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.
Digital HealthHealthtechMedical DevicesSeattle, US
Ben Casavant(Co-Founder and Chief Executive Officer)inErwin Berthier(Co-Founder and Chief Technology Officer)inAlan Levy(Director)
BoardElizabeth Hambrecht(Director)Paul Conley(Director)in
Co-investorsForesite CapitalJ2 VenturesMerck Global Health Innovation FundMSD Global Health Innovation FundRA CapitalTechstars+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.